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Abstract 
The effects of magnesium supplementation on blood pressure (BP) have been studied for 
over 25 years and results have been inconsistent. Blood pressure reductions in 
randomized studies have varied from 12 mmHg reductions to no reduction. The objective 
of this pilot intervention was to investigate the effect of magnesium supplementation on 
systolic blood pressure whilst resting and during recovery from aerobic and resistance 
exercise and on performance. A further objective was to see whether the effect of a high 
vs low habitual dietary magnesium intake affected these results.  Sixteen male volunteers 
were randomly assigned to either a 300mg/d magnesium oxide supplementation (MO) or 
a control group (CG) for 14 days.  Resting blood pressure (BP) and heart rate (HR) were 
measured before subjects performed a maximal 30 minute cycle, immediately followed 
by three x 5 second isometric bench press, both at baseline and after the intervention. 
Blood pressure and heart rate were recorded immediately post exercise and after five 
minutes recovery. A 3 day food diary was recorded for all subjects to measure dietary 
magnesium intake. At the end of the intervention, the supplemented group, had a 
reduction in mean resting systolic BP by 8.9 mmHg (115.125 ± 9.46 mmHg, P=0.01) and 
post exercise by 13 mmHg (122.625 ± 9.88 mmHg, P=0.01). Recovery BP was 11.9 
mmHg lower in the intervention group compared to control (P=0.006) and HR decreased 
 
 
by 7 beats per minute in the experimental group (69.0 ± 11.6 bpm, P=0.02). Performance 
indicators did not change within and between the groups. Habitual dietary magnesium 
intake affected both resting and post exercise systolic BP and the subsequent effect of the 
magnesium supplementation. These results have an implication in a health setting and for 
health and exercise but not performance.  
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Introduction. 
Magnesium, one of the most abundant minerals in the body, is essential for over 300 
biochemical processes and plays important roles in activating cellular enzymatic 
activity, such as those needed to synthesize DNA and RNA, and also in metabolism 
(Musso, 2009). For athletes it is important because of its involvement in glycolysis, the 
citric acid cycle and creatine phosphate production. It has also been suggested that free 
magnesium levels can affect excitation contraction coupling of the myocardium 
(Michailova et al., 2004).  Magnesium has been consistently linked with a reduction in 
blood pressure within both a clinically hypertensive population and a normotensive 
population (Itoh, Kawasaki and Nakamura, 1997). Meta-analyses of randomized studies 
by Jee, et al., (2002) and Kass et al., (2012) on the effects of magnesium on BP shows 
dose dependent reductions. A study by Itoh et al., (1997) on 33 normotensive patients 
showed that magnesium lowered BP after 4 weeks.  The authors attributed the reduction 
to the excretion of sodium in urine which acts as a relaxant to the blood vessels.  
However, Doyle et al., (1999) performed a study on healthy females and found no 
reduction in BP with increased magnesium intake after 4 weeks.  
 
Exercise causes magnesium levels in the body to be depleted through losses in sweat, 
urine and alterations in the blood magnesium levels (Rayssiguier et al., 1990). An 
athlete will therefore have a higher requirement for daily magnesium intake than the 
sedentary population.  Athletes on calorie restricted diets may also be at risk of 
deficiency.  
 
 
 
Evidence shows that exercise causes a redistribution of magnesium to the active sites in 
the body (Nielsen and Lukaski, 2006), and that deficiency of the mineral negatively 
affects performance (Newhouse and Finstad, 2000). However, there has been little 
evidence to show that magnesium supplementation in adults with adequate magnesium 
intake will increase performance (Laires and Monteiro, 2007).  
 
There are two suggested mechanisms for the effect of magnesium on systolic BP at rest. 
One mechanism is that magnesium acts as a driving force of the sodium potassium 
pump in the cell membrane and mobilizes more sodium to be excreted (Bara et al., 
1993). Reduction of intracellular sodium may cause the smooth muscle cells in the 
vascular walls to relax and BP to reduce. Another suggested mechanism is that 
magnesium acts as a calcium channel blocker (Touyz, 2004), working as a relaxant of 
the smooth muscle in blood vessels, increasing arterial compliance and reducing BP.   
 
There have been suggestions of an inverse relationship between daily dietary 
magnesium intake and BP (Ma et al. 1995., Kawano et al, 1998), however, dietary 
magnesium is rarely assessed in the studies reviewed and no large studies have looked 
at the impact of dietary magnesium on BP in hypertensive patients. Common foods 
which contain magnesium are grains such as buckwheat flour and oat bran, vegetables 
such as artichoke, spinach and black and white beans and nuts for example almonds and 
brazils.  It should be considered however that the daily dietary intake of magnesium in 
Western society has been declining from about 500mg day
-1
 in the 1900’s to a value 
closer to 175mg day
-1
 (Altura, 1994), increasing the likelihood of an individual being 
 
 
deficient in magnesium. This figure falls someway short of the current UK RNI outlined 
by the UK Food Standards Agency, (2003) of 300mg d
-1
 for men and 270mg d
-1
 for 
women (12.35mmol & 11.1mmol).  
 
To the best of the authors’ knowledge, no studies have addressed how magnesium 
impacts maximal aerobic exercise and performance in healthy individuals.  Further there 
are no studies which look at the effect of magnesium supplementation in those with a 
high vs low habitual dietary magnesium intake. 
 
Although reviews have shown a reduction in blood pressure with magnesium 
supplementation, (Kass et al., 2012; Jee et al., 2002) there is limited research on the 
effect of supplementation on BP during exercise or on performance.  It is important for 
magnesium levels to stay high during recovery to affect cellular metabolism and protein 
synthesis (Groff and Gropper, 2000). Therefore low magnesium levels may impair 
muscle recovery and BP during and post exercise. Normal BP response post exercise is 
rapid hypotension (Orri et al., 2004). However, this may differ in response to 
magnesium supplementation and in the extent of hypotension.  
 
The aims of this pilot investigation were to determine 1) the relationship between 
magnesium supplementation and systolic BP at rest and post exercise and its effect on 
performance, 2) to determine whether a high or low dietary magnesium intake impacts 
on these results. Further objectives were to investigate any changes in heart rate 
throughout. 
 
 
 
Methodology 
 
Subjects       
Sixteen male subjects were recruited. They were all undertaking aerobic exercise (>4 
hours per week), apparently healthy and with no physical impairments. Exercise was 
defined as any physical activity perceived to be at 13 or above on The Borg Scaling of 
Perceived Exertion. Fifteen subjects were white Caucasian and 1 was Asian. Subjects 
volunteered to take part in the project and completed a consent form and health screen.  
Ethical approval was received from The University of Hertfordshire, Life Science 
Ethics Committee. Full inclusion and exclusion criteria can be seen in table 1. 
 
 
 
Design  
Subjects were randomized to either the supplement or the control group. Subjects in 
both groups were asked to come in for familiarization and then twice for testing over a 4 
week period, with only the experimental group taking the magnesium supplementation 
and the control group undertaking the same tests but with no supplementation.  A total 
of 3 visits to the laboratory were required from each of the subjects. 
 
Protocol 
Familiarization and Test 1 –  
Diet - Subjects were asked to complete a 3 day dietary recall to assess habitual 
magnesium dietary intake using dedicated software (Dietplan 6.50 Forestfield Software 
 
 
Ltd., West Sussex, UK).  Dietary intake was categorized into high and low categories 
based on the Committee on Medical Aspects of Food and Nutrition Policy (COMA, 
1991) calculated a Reference Nutrient Intake (RNI) of 300 mg/day for adult males 
(<300mg.d
-1
 and ≥300mg.d-1).  
 
Supplementation - Supplements consisted of a vegetarian capsules filled with 150mg of 
medical grade Magnesium Oxide Light 13138 (Sigma-Aldrich, Missouri, USA).  Each 
capsule was individually weighed (Ohaus adventurer balance AR1530 New Jersey, 
USA), Subjects were instructed to take two tablets per day resulting in a total of 300mg 
per day per subject, one in the morning on waking, and at the end of the day for a total 
of 14 days.   
Exercise familiarization – On the first visit to the laboratory subjects were shown the 
equipment and the full protocol was carried out as described below in order that the 
subjects were able to familiarize themselves with the process.  They were then invited 
back to the laboratory in a time frame of 3-7 days after familiarization had taken place 
for the protocol to be repeated and baseline measurements recorded. Supplementation 
was distributed after baseline measurements were recorded.  The protocol was  repeated 
14 days after baseline measurements had been taken. 
 
Exercise protocol - Following 10 minutes of silent rest, a 3 minute warm up at self-
selected pace was undertaken on the cycle ergometer (Monark Ergomedic 874 E Cycle 
Ergometer, Monark Sports and Medical, Sweden), with 1kg load, with heart rate kept 
below 140bpm. A Polar T31 transmitter (Polar Electro Oy, Kempele, Finland), 
measured heart rate throughout all exercise. Subjects then cycled on the cycle ergometer 
 
 
with a 1kg load for 30 minutes at their maximal capacity in order to achieve the greatest 
distance in the allocated time. After completion of the 30 minute maximal cycle a two 
minutes rest was given with subjects being advised to continue to pedal for at least 60 
seconds of the two minute interval at self-selected intensity that was lower than that 
undertaken during the 30 minute trial. After the two minute interval, 3 x 5 second 
maximal isometric bench press contractions were completed, each separated by a 30 
seconds rest.  The isometric contraction was undertaken with the subject supine on a 
bench and pushing maximally against a static metal bar on the Marcy Smith Machine 
Plus, (Marcy Fitness Products, Ontario, Canada) and measured by a Digital Analyser 
Isometric Transducer (MIE Medical Research Ltd., Yorkshire, UK). The 3 isometric 
bench press weights were averaged and percentage change calculated between baseline 
and week 2. As subjects differed in size, bench press output results could be skewed due 
to the different size of the levers. Therefore, the joint angle of the upper arm and 
shoulder was standardized to 40°. 
 
Measurements pre and post-exercise from rest to recovery - After 10 minutes of silent 
rest, BP was measured from the right arm (Omron MX3, Omron Healthcare, Kyoto, 
Japan). At timepoint 15 minutes, during the 30 minute maximal cycle, gas was analyzed 
for O2 and CO2 using Cortex Biophysik Metalyser 3B (Leipzig, Germany) with 
Metasoft 3.9.2 software. Gas was collected again at the 30 minute time mark and 
respiratory exchange ratio (RER) calculated. After completing all three of the isometric 
contractions, BP was measured again. A 5 minute seated recovery period then took 
place with subjects having a final BP and heart rate measurement taken at this time.  
 
 
 
Heart rate (HR) was measured pre and post-exercise and recorded 4 times throughout 
the protocol.  Total HR recordings were at Pre-exercise at rest (RHR), after 15 minutes 
cycling (HR15), at the end of Exercise (HR30),  and post-exercise, after 5 minutes 
recovery (RecHR).  
 
Test 2 - After 14 days both groups repeated the exercise protocol, with the same 
measurements being taken.  Subjects came in on the same time of day, and the same 
tester was present during both tests for all subjects.  
 
 
Data analysis 
Food diaries were input into Dietplan 6 (Dietplan 6.50 Forestfield Software Ltd., West 
Sussex, UK) and subjects were stratified into high and low habitual dietary magnesium 
intake based on these results.  Data were then analyzed for the cohort as a whole and 
again stratified for low and high habitual dietary intake.   All data were analyzed using 
Excel and SPSS7 ( PASW Statistics v17.0.2 IBM, New York, USA) and tested for 
normality using a Shapiro-Wilk test. As the data were normally distributed, independent 
t-tests were performed between groups, and dependent paired t-tests between tests to 
assess significance. The alpha value was set at 0.5. 
 
 
 
 
 
 
 
Results 
 
Sixteen male subjects were recruited (age 20.88 ±1.82 yrs, height 180.47 ± 6.77 cm, 
weight 73.91 ± 12.49 kg, resting systolic blood pressure 124.63 ± 6.05mmHg). Baseline 
characteristics were further broken down into the control and experimental group (table 
2).  No statistical significance difference was found between the groups.  
 
In the supplemental group three subjects were above the RDA (300mg.d
-1
) and 5 were 
below.  The control group had an even amount of subjects above and below the RDA.  
 
Blood Pressure 
At baseline there were no significant differences between the groups in blood pressure 
at any of the time points (table 3). Post intervention there was as a significant difference 
between the control and the supplemented group for resting pre-exercise, post and 
recovery blood pressure. A significant difference from baseline was also seen in the 
supplemented group for resting pre-exercise and post exercise blood pressure after 2 
weeks supplementation. 
 
RSBP decreased by 7.7% post intervention in the experimental group compared to 
baseline (p=0.017) and inter-group between experimental and control post intervention 
(p=0.014). Post SBP decreased by 10.6% at follow-up in the experimental group 
compared to baseline (p=0.017) and between experimental and control groups at follow 
up (p=0.000) (table 3). 
 
 
 
Rec SBP decreased by 7.0% at follow-up in the experimental group compared to 
baseline (P=0.006) although no significance was found for Rec SBP at follow-up 
between the baseline and experimental group (table 3). 
 
 
Habitual dietary magnesium intake 
There was no significant difference found for habitual magnesium intake between 
control and experimental subjects (P=0.18). When stratified by dietary magnesium 
intake, the supplemented group showed significance  in resting systolic BP at week 2 
compared to baseline for the low habitual dietary magensium intake  (114.0± 11.6 
mmHg, P=0.02) (figure 1) and in the high magnesium intake group post exercise (120.7 
± 1.5 mmHg, P=0.01) (figure 2).  The control group showed no significant change in 
either resting or post exercise SBP at week 2 compared to baseline (figures 1 & 2). 
However, significance was found in resting systolic BP at week 2 compared to baseline 
in the low magensium intake group (114.00 ± 11.60 mmHg, P=0.02) within the 
intervention group.  
 
Performance 
Cycling time trial distance increased from baseline to week 2 significantly in both 
groups, however this increased distance was lower at week 2 in the supplemented group 
compared to the control group.  In the experimental group baseline distance was 20.5 ± 
2.5 Km and after the intervention increased to 22.7 ± 2.4Km an increase of 10.6%. 
However, in the control group baseline distance was 19.4 ± 1.8 Km and at the end of the 
trial was 22.1± 2.3 Km, an increase of 14.1%.   
 
 
 
The 3 isometric bench press weights were averaged and percentage change calculated 
between baseline and week 2.  Average strength increased by 11.4% in the control 
group, from 24.2±8.67kg to 26.9±8.08kg and decreased by 18.0% in the experimental 
group from 35.5±16.72kg to 29.0±10.88kg.  No significant changes were shown.  
 
Heart Rate and RER 
No significant difference was found between the control group and the experimental 
group at any time point. For the RER at the 30 minute time point the intervention group 
changed from 1.14±0.13 to 1.10±0.07 from baseline to week 2 and the control group 
from 1.06±0.03 to 1.11±0.02 from baseline to week 2.  No significance change was 
shown. For heart rate, as expected, significance was found timewise in the change from 
resting to recovery heart rate and throughout the 30 minute cycle in both the control and 
supplemented group (table 3).  
 
Discussion 
 
In this pilot study resting, post exercise and recovery systolic BP significantly decreased 
from baseline to week 2 for the magnesium supplemented group when compared to the 
control group. This is consistent with other studies that have reported significant 
reductions of 4.1 mmHg and 5 mmHg respectively for systolic BP (Kawano et al.,1998; 
Itoh et al.,1997).  
 
 
 
Different to most supplementation studies, this pilot investigation looked at whether 
habitual magnesium intake influenced the BP results at both resting and post exercise 
conditions. The data were used to stratify results for both the supplemented and control 
group into high and low magnesium intake. Although not the main focus for the study 
and the study is not powered to examine this, there is an indication that allowed 
consideration to be given as to whether supplementation showed the same changes in 
those who have a naturally high dietary intake of magnesium as to those who have a 
low dietary intake.  In the control group for both the high and low habitual magnesium 
intake, resting systolic BP did not change at week 2 compared to baseline. However, a 
significant lowering was found in resting systolic BP at week 2 compared to baseline in 
the low magensium intake group within the intervention group. This suggests that 
magnesium supplementation may have a greater effect on resting BP in subjects that 
have a low habitual dietary magnesium intake than those who have a naturally higher 
intake above the RNI.  
 
Sanjuliani, de Abreu Fagundes  and Francischetti (1996)  found over 10 mmHg 
reduction in mean BP with 600 mg.
d
 oral magnesium oxide supplement in hypertensive 
patients. They attributed this significant reduction to decreased intracellular sodium 
levels and increased magnesium levels in the blood.  
 
Conversely, two studies found no evidence for the role of increased dietary magnesium 
intake in the reduction of high BP. One study was in women only (Doyle et al., 1999) 
and magnesium was increased through diet alone but was still below the US RDA.  
 
 
 
Mean post exercise BP showed the opposite. The results showed mean post exercise 
systolic BP significantly decreased by 24.3 mmHg at week 2 when compared to 
baseline, in the high magnesium intake subgroup of the experimental group (20.2%, 
P=0.017). This shows that magnesium supplementation has a bigger effect on post 
exercise BP in subjects that have a high magnesium intake. The mechanism for this is 
not explained in the literature. It may be due to the increased demands of magnesium for 
a physically active person during exercise as it is bound to ATP or that a higher plasma 
concentration may result in more magnesium being used as a relaxant of the smooth 
muscle cells in the vascular walls. This has implications in health.  Patients suffering 
from hypertension could gain larger BP reductions from a combined dietary change and 
oral supplementation program. 
 
Secondary to the main aim, this investigation set out to determine whether 
supplementation had an effect on aerobic and resistance performance. For the 30 minute 
cycling time trial the results showed a significant increase of 2.74 kilometers and 2.19 
kilometers for mean cycling time trial distance in both control and experimental groups. 
However, there was no significance found between groups. A review by Newhouse and 
Finstad (2000) supports this. They reviewed 33 years of research and concluded that 
most evidence shows no enhancement of performance. However, a study by Cinar et al. 
(2007) found that magnesium supplementation did improve performance of subjects 
who were exercising for 90-120 minutes per day for 5 days a week, rather than 2 
separate bouts of exercise 14 days apart. The suggested mechanism for the increase is 
that magnesium increases the red blood cell count and hemoglobin levels, allowing 
greater oxygen distribution.  
 
 
 
For the isometric bench presses the results showed the average strength increased in the 
control group by 11.4% and decreased by 18.0% in the experimental group, showing a 
29.4% difference between the groups at week 2, although baseline and week 2 data were 
higher in the experimental group compared to control group throughout. None of the 
data were significant at either baseline or week 2 although a non-significant difference 
could be seen partly due to the fact that the experimental group had a higher baseline 
value than the control group.  Much of the literature shows the contrary (Brilla and 
Haley, 1992;  Domiguez et al., 2006).  Reasons for this may be due to higher dosages of 
supplements (8mg/kg/bw) over a longer period of supplementation (7 weeks) and 
untrained individuals rather than active subjects being used. For resistance exercise and 
isometric contractions magnesium supplementation has shown to produce mixed results 
on performance. A study by Brilla and Haley (1992) found a 20% strength increase of 
peak knee extension torque which they attributed to magnesium’s role at ribosomal 
level. However, a review of supplemental effects by Clarkson (1991) identified no 
relationship between magnesium supplementation and performance at any dosage.     
Magnesium also activates amino acids and aids the attachment of mRNA to the 
ribosomes in protein biosynthesis (Groff and Gropper, 2000). This is important in 
increasing strength and protein synthesis during resistance exercise and recovery. 
Magnesium has been shown to enhance insulin-like growth factor 1 (IGF-1) which may 
elevate testosterone (Dominguez et al., 1998). Both being anabolic hormones, 
supplementation of magnesium may increase strength when given alongside an exercise 
training program.    
  
 
 
Limitations to this pilot study included the short supplementation period of only 2 
weeks and also small sample size.  Although the cohort were matched for weekly 
physical activity levels a more robust test of fitness, such as VO2max testing was not 
carried out.  Dietary intake was recorded for 3 days to assess habitual dietary 
magnesium intake.  A cross-over design would also enhance the effect of the 
supplementation and allow for the trial to be double blinded. 
 
Conclusion. 
 
In this pilot study, oral magnesium supplementation significantly reduces resting and 
post exercise BP.  Furthermore, in those with a low background dietary magnesium 
intake there was a greater effect of supplementation on resting BP than those with a 
high dietary magnesium intake.  Conversely, post exercise BP was reduced more in 
those with a high dietary magnesium intake. This pilot suggests that the effect of 
magnesium supplementation is relevant mainly in a health context rather than 
performance as no enhancements in athletic performance were found. Further research 
could investigate the effects of higher and longer dosages of magnesium 
supplementation on both aerobic and resistance exercise performance.  An analysis of 
dietary intake looking at habitual magnesium intake in those showing resting 
hypertension would also aid in the understanding of magnesium and blood pressure 
 
Conflict of interest statement: The authors declare that they have no conflict of interest 
 
 
 
 
 
 References 
Bara, M., Guiet-Bara, A. and Durlach, J. (1993). Regulation of sodium and potassium 
pathways by magnesium in cell membranes. Magnes Res. 6(2), 167-177 
 
Bohl, C.H. and Volpe, S.L. (2002) Magnesium and Exercise. Crit Rev Food Sci Nutr. 
42(6), 533-563 
 
Brilla, L.R. and Haley, T.F. (1992). Effect of magnesium supplementation on strength 
training in humans. J Am Coll Nutr., 11(3), 326-329 
 
Cinar, V., Nizamlioglu, M., Mogulkoc, R. and Baltaci, A.K. (2007). Effects of 
magnesium supplementation on blood parameters of athletes at rest and after exercise. 
Biological Trace Element Research 115(3), 205-212 
 
Clarkson, P.M. (1991). Minerals: exercise performance and supplementation in athletes. 
J.  Sports Sci. 9, 91-116 
 
COMA (1991). Dietary Reference Values for Food Energy and Nutrients for the United 
Kingdom. Report of the Panel on Dietary Reference Values, Committee on Medical 
Aspects of Food and Nutrition Policy. HMSO: London. 
 
Cappuccio,F.P., Markandu, N.D., Beynon, G.W., Shore, A.C., Sampson, B. and 
MacGregor, G.A. (1985). Lack of effect of oral magnesium on high blood pressure: a 
double blind study. Br. Med. J., 291, 235-238. 
 
Dominguez, L.J., Barbagallo, M., Sowers, J.R. and Resnick, L.M. (1998). Magnesium 
Responsiveness to Insulin and Insulin-Like Growth Factor I in Erythrocytes from 
Normotensive and Hypertensive Subjects. J. Clin. Endocrinol. Metab. 83, 4402-4407  
 
Dominguez, L.J., Barbagallo, M., Lauretani, F., Bandinelli, S., Bos, A., Corsi, A.M., 
Simonsick, E.M. and Ferrucci, L. (2006). Magnesium and muscle performance in older 
persons: the InCHIANTI study. Am. J. Clin. Nutr. 84(2), 419-426 
 
 
 
Doyle, L., Flynn, A. and Cashman, K. (1999). The effect of magnesium 
supplementation on biochemical markers of bone metabolism or blood pressure in 
healthy young adult females. Eur. J. Clin. Nutr. 53(4), 255-261 
 
Elin, R.J. (1988). Magnesium metabolism in health and disease. Dis. Mon 34(4), 161-
218 
 
Finstad, E. W., Newhouse, I. J., Lukaski, H. C., McAuliffe, J. E., and Stewart, C. R. 
(2001). The effect of magnesium supplementation on exercise performance. Med. Sci. 
Sports. Exer. 33, 493-498. 
 
Golf, S.W., Happel, O., Graef, V. and Seim, K.E. (1984). Plasma aldosterone, cortisol 
and electrolyte concentrations in physical exercise after magnesium supplementation. J 
Clin Chem Clin Biochem 22(11), 717-721 
 
Groff, J.L. and Gropper, S.S. (2000). Advanced Nutrition and Human Metabolism. (3
rd
 
ed.). California: Wadsworth 
 
Itoh, K., Kawasaki, T. and Nakamura, M. (1997). The effects of high oral magnesium 
supplementation on blood pressure, serum lipids and related variables in apparently 
healthy Japanese subjects. Br. J. of Nutr., 78(5), 737-750 
 
Jee, S.H., Miller III, E.R., Guallar, E., Singh, V.K., Appel, L.J. and Klag, M.J. (2002). 
The effect of magnesium supplementation on blood pressure: a meta-analysis of 
randomized clinical trials. Am J Hypertens 15, 691-696 
 
Kass, L., Weekes, J., Carpenter, L. (2012) Effect of magnesium supplementation on 
blood pressure: a meta-analysis. Eur J Clin Nutr.  66(4):411-8.  
 
 
 
Kawano, Y., Matsuoka, H., Takishita, S. and Omae, T. (1998). Effects of Magnesium 
Supplementation in Hypertensive Patients. Hypertension 32 (2), 260-265 
 
Laires, M.J. and Monteiro, C. (2007). Exercise and Magnesium. New Perspectives in 
Magnesium Research 14, 173-185 
 
Loosli, A. R., Benson, J., Gillien, D. M., and Bourdet, K. (1986). Nutrition habits and 
knowledge in competitive adolescent female gymnasts. Physician and Sportsmedicine. 
14,118–130. 
 
Ma J, Folsom AR, Melnick SL,  Eckfeldt JH,  Sharrett, AR, Nabulsi AA, Hutchinson 
RG & Metcalf PM (1995) Associations of serum and dietary magnesium with 
cardiovascular disease, hypertension, diabetes and carotid arterial wall thickness: The 
ARIC study. Journal of Clinical Epidemiology. 48(7), 927-940. 
 
McDonald, R. and Keen, C. (1988) Iron, zinc, and magnesium nutrition and athletic 
performance. Sports Med. 5, 171-184. 
 
Michailova, A.P., Belik, M.E. and McCulloch, A.D. (2004). Effects of magnesium on 
cardiac excitation-contraction coupling. J Am College Nutr.  23(5), 514S-517S 
 
Musso, C, G., (2009) Magnesium metabolism in health and disease.  Int Urol Nephrol. 
41(2), 357-362  
 
 
Newhouse, I.J. and Finstad, E.W. (2000) The Effects of Magnesium Supplementation 
on Exercise Performance. Clinical Journal of Sports Medicine. 10(3), 195-200 
 
Nielsen, F.H. and Lukaski, H.C. (2006). Update on the relationship between magnesium 
and exercise. Magnes Res. 19(3), 180-189 
 
 
 
Orri, J.C., Griffin, S.E., Robergs, R.A., James, D.S., Wagner, D.R. and Quintana, R. 
(2004). Intra-arterial blood pressure characteristics during submaximal cycling and 
recovery. J. Ex. Phys. 7(2), 45-53 
 
Rayssiguier, Y., Guezennec, C.Y., and Durlach, J. (1990). New experimental and 
clinical data on the relationship between magnesium and sport. Magnes. Res. 3, 93–102. 
 
Sanjuliani, A.F., de Abreu Fagundes, V.G. and Francischetti, E.A. (1996). Effects of 
magnesium on blood pressure and intracellular ion levels of Brazilian hypertensive 
patients. International Journal of Cardiology 56(2), 177-183 
 
Terblanche, S., Noakes, T.D., Dennis, S.C., Marais, D. and Eckert, M. (1992). Failure 
of magnesium supplementation to influence marathon running performance or recovery 
in magnesium-replete subjects. Int. J. Sports Nutr. 2, 154–164. 
 
Touyz, R.M. (2004). Magnesium in clinical medicine. Frontiers in Bioscience 9, 1278-
1293 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
